The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
Edwards received information that moderate paravalvular leak from this 25mm 8300ab valve was observed by echo approximately three (3) years and one (1) month after implantation.The device was not exchanged, and medication was performed.The patient status was reported as 'under treatment'.The doctor commented that it was unknown whether this event was device related.After implant duration of three (3) years and seven (7) months, the device was explanted and replaced with a 23mm 11500 valve.The patient status was 'recovered'.
|
H10: corrected data: corrected sections h6 (component code as it was blank and should have read "4755-part/component/sub-assembly term not applicable" on the initial fda report, type of investigation, investigation findings, investigation conclusions), h11 (additional manufacturer narrative) regurgitation which develops progressively over time can be due to a number of issues including patient related factors or structural valve deterioration.Structural valve deterioration (svd) can, and typically does, lead to chronic central leaks over a period of time.Svd is the most common reason for bioprosthesis explant and encompasses multiple failure modes, including calcification, non-calcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes may occur singularly or concomitantly.Tissue degeneration-related structural deterioration, either calcific or non-calcific, are common chronic failure modes for this type of bioprosthetic heart valve.Operational mechanical stress and biological factors are generally believed to be the major contributors to the non-calcific bioprosthetic tissue degeneration.The root cause of this event cannot be conclusively determined with the available information.However, the regurgitation in this case was likely impacted by the progression of the patient's underlying valvular disease pathology with or without structural valve deterioration and/or nonstructural dysfunction.The subject device is not available for evaluation as it was discarded.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|